RAPT Therapeutics
RAPT
RAPT was delisted on the 2nd of March, 2026.
105 hedge funds and large institutions have $1.02B invested in RAPT Therapeutics in 2025 Q4 according to their latest regulatory filings, with 49 funds opening new positions, 36 increasing their positions, 9 reducing their positions, and 8 closing their positions.
7,387% more call options, than puts
Call options by funds: $22.1M | Put options by funds: $295K
513% more first-time investments, than exits
New positions opened: 49 | Existing positions closed: 8
300% more repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 9
139% more capital invested
Capital invested by funds: $428M → $1.02B (+$594M)
62% more funds holding
Funds holding: 65 → 105 (+40)
9.04% more ownership
Funds ownership: 100.35% → 109.39% (+9%)
0% more funds holding in top 10
Funds holding in top 10: 9 → 9 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FIS
FCPM III Services
Naarden,
Netherlands
|
+$46.2M |
| 2 |
FLSM
Frazier Life Sciences Management
Palo Alto,
California
|
+$30.5M |
| 3 |
TCM
TCG Crossover Management
Palo Alto,
California
|
+$29.4M |
| 4 |
B
Braidwell
Stamford,
Connecticut
|
+$28.9M |
| 5 |
SL
Siren LLC
Greenwich,
Connecticut
|
+$24.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$19.9M |
| 2 |
BCM
Boone Capital Management
Atlanta,
Georgia
|
-$9.69M |
| 3 |
SC
SummitTX Capital
Fort Worth,
Texas
|
-$2.37M |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$1.33M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
-$1.3M |
RAPT Hedge Fund Activity: Q4 2025 in Review
105 of the 8,224 institutional investors tracked by Wall St. Rank reported a position in RAPT Therapeutics (RAPT) for Q4 2025, worth a combined $1.02B — up 139% from $428M a quarter earlier.
Buyers outnumbered sellers: 49 funds opened new RAPT positions and 8 closed out — a net gain of 41 holders — while 36 added to existing stakes and 9 trimmed.
The largest buyer was FCPM III Services, adding an estimated $46.2M. The largest seller was Deep Track Capital, cutting an estimated $19.9M.
- 105 institutional investors held RAPT Therapeutics (RAPT) as of Q4 2025, up from 65 in Q3 2025.
- Funds reported $1.02B of RAPT Therapeutics stock for Q4 2025, up 139% quarter-over-quarter.
- 49 funds opened new RAPT Therapeutics positions in Q4 2025 and 8 closed out, a net change of +41 holders.
- The largest RAPT Therapeutics buyer in Q4 2025 was FCPM III Services, an estimated $46.2M added.
- The largest RAPT Therapeutics seller in Q4 2025 was Deep Track Capital, an estimated $19.9M sold.
Based on aggregated 13F filings for Q4 2025.